Balance Sheet

Cash Flow Statement

Acquisitions Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Mobix Labs (MOBX) Cash from Restructuring (2023)

Mobix Labs has reported Cash from Restructuring over the past 1 years, most recently at $4.0 million for Q4 2023.

For Q4 2023, Cash from Restructuring changed N/A year-over-year to $4.0 million; the TTM value through Sep 2024 reached $4.0 million, changed N/A, while the annual FY2024 figure was $4.0 million, N/A changed from the prior year.
Cash from Restructuring for Q4 2023 was $4.0 million at Mobix Labs.
Over five years, Cash from Restructuring peaked at $4.0 million in Q4 2023 and troughed at $4.0 million in Q4 2023.